Latest Annual General Meeting News

Page 2 of 82
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Western Gold Resources has secured $7.5 million to begin Gold Duke site establishment and a 12,000-metre life-of-mine extension drilling campaign. Forrestania Resources will provide $5.5 million and emerge with a 17.61% holding if the two-tranche placement is completed.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Regis Healthcare delivered higher revenue, earnings and cash generation in FY26, but its new CEO is confronting a sharp funding gap across the aged care sector. The company plans to offset weaker AN-ACC support through pricing, cost reductions and further expansion.
Ada Torres
Ada Torres
17 Nov 2026
Beacon Minerals has declared a fully franked dividend of 5 cents per share, taking total dividends paid since 2016 to 88 cents per share. The filing also contains a payment-date discrepancy that shareholders may need to clarify before the distribution is processed.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Aureka has completed its $8.9 million acquisition of the operating Fiddlers Creek mine and Wedderburn processing mill, moving from explorer to producer. The company now faces the harder test: turning spare mill capacity and a small-scale mine into dependable cash generation.
Maxwell Dee
Maxwell Dee
16 Nov 2026
Manhattan Gold has completed its A$4.5 million placement, removing the shareholder-approval overhang on funding for its Hook Lake exploration program. The company has also disclosed preliminary, non-binding discussions with a US resources group over a possible earn-in and joint venture.
Maxwell Dee
Maxwell Dee
16 Nov 2026
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
Carma has reaffirmed its target for FY27 revenue growth above 80% and says it expects to reach positive EBITDA before the end of calendar 2027. The online used-car retailer is relying on record early trading, AI-led productivity gains and a second reconditioning shift to close the gap between scale and profitability.
Victor Sage
Victor Sage
13 Nov 2026
RBR Group has secured A$600,000 through a placement and reworked all A$1.25 million of its convertible notes, giving it near-term funding to deliver its first post-restart Rovuma LNG contract. The financing strengthens the bridge to execution, but leaves shareholders facing further dilution and the company still dependent on future awards.
Victor Sage
Victor Sage
13 Nov 2026
Australian Bond Exchange says FY2026 marked a sharper recovery, with revenue up 47% and two consecutive quarters of positive operating cash flow. But the ASX-listed fixed-income group remains loss-making, carries $2 million of convertible-note maturities in 2027 and faces a going-concern uncertainty.
Claire Turing
Claire Turing
13 Nov 2026
Servcorp has reaffirmed FY27 guidance after delivering a third successive record year, with cash generation expected to rise even as underlying profit remains broadly steady. The company is targeting dividends of at least 34 cents per share while focusing on filling newer locations and expanding technology-led services.
Victor Sage
Victor Sage
12 Nov 2026
Bridge SaaS ended September with just A$31,000 in cash after a A$1.455 million operating outflow, leaving an estimated 0.02 quarters of funding. The company says its solvency depends on lower costs and timely NDIS receipts, while a potential A$2 million placement remains uncommitted.
Victor Sage
Victor Sage
12 Nov 2026

Browse the archive

Full archive